Scalper1 News
Biotech and pharmaceutical companies are on the rise with life-saving promises, adding to hopes that their stocks will also be healthy investments. The industry was down Friday on general market weakness and concerns over growth stocks. But it continues to dominate this week’s IBD 50, which lists companies based on superior earnings, strong price performance and leadership within industries. Here are the top six drugmakers on the the list. Salix Scalper1 News
Scalper1 News